N1-(3,4-dimethoxyphenethyl)-N6-phenethyladipamide(WXG02106)

그림문자(GHS)

• 그림문자(GHS)

  

• 신호 어

  Warning

• 유해·위험 문구

  H302：삼키면 유해함

• 예방조치문구

  P264：취급 후에는 손을 철저히 씻으시오.

  P264：취급 후에는 손을 철저히 씻으시오.

  P270：이 제품을 사용할 때에는 먹거나, 마시거나 흡연하지 마시오.

  P301+P312：삼켜서 불편함을 느끼면 의료기관(의사)의 진찰을 받으시오.

  P330：입을 씻어내시오.

  P501：...에 내용물 / 용기를 폐기 하시오.

N1-(3,4-dimethoxyphenethyl)-N6-phenethyladipamide(WXG02106) 화학적 특성, 용도, 생산

• 용도

  N-[2-(3,4-Dimethoxyphenyl)ethyl]-N''-(2-phenylethyl)-hexanediamide is an intermediate of Dopexamine (D533900), which is a synthetic dopamine analog and acts as a a β2-adrenergic receptor agonistt as well as an agonist at peripheral dopamine receptors. Dopexamine has been used to improve myocardial and renal performance in patients suffering from low cardiac output states.

N1-(3,4-dimethoxyphenethyl)-N6-phenethyladipamide(WXG02106) 공급 업체

Global(7)Suppliers